Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Center | 7 | 2012 | 53 | 1.870 |
Why?
|
| Neurons | 14 | 2016 | 1546 | 1.590 |
Why?
|
| Biological Clocks | 7 | 2008 | 74 | 1.450 |
Why?
|
| Periodicity | 6 | 2011 | 119 | 1.450 |
Why?
|
| Neocortex | 4 | 2019 | 95 | 1.230 |
Why?
|
| Synaptic Transmission | 6 | 2019 | 222 | 0.990 |
Why?
|
| TRPC Cation Channels | 3 | 2014 | 21 | 0.920 |
Why?
|
| Nerve Net | 12 | 2021 | 366 | 0.910 |
Why?
|
| Respiration | 4 | 2009 | 262 | 0.860 |
Why?
|
| Respiratory Mechanics | 4 | 2008 | 102 | 0.810 |
Why?
|
| Action Potentials | 9 | 2016 | 573 | 0.790 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 49 | 0.690 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2012 | 48 | 0.670 |
Why?
|
| Patch-Clamp Techniques | 11 | 2021 | 396 | 0.610 |
Why?
|
| Electroencephalography | 3 | 2022 | 709 | 0.590 |
Why?
|
| Seizures | 1 | 2019 | 297 | 0.590 |
Why?
|
| Medulla Oblongata | 4 | 2005 | 89 | 0.540 |
Why?
|
| Respiratory Burst | 2 | 2006 | 18 | 0.530 |
Why?
|
| In Vitro Techniques | 10 | 2021 | 989 | 0.480 |
Why?
|
| Substance P | 2 | 2010 | 61 | 0.430 |
Why?
|
| Sodium Channels | 4 | 2011 | 129 | 0.420 |
Why?
|
| Rhombencephalon | 1 | 2012 | 50 | 0.420 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2012 | 52 | 0.410 |
Why?
|
| Organoids | 2 | 2021 | 61 | 0.390 |
Why?
|
| Cockroaches | 2 | 2000 | 10 | 0.380 |
Why?
|
| Epilepsy | 2 | 2011 | 397 | 0.370 |
Why?
|
| Sodium | 2 | 2008 | 341 | 0.360 |
Why?
|
| Biogenic Monoamines | 1 | 2009 | 8 | 0.360 |
Why?
|
| Walking | 2 | 2000 | 87 | 0.350 |
Why?
|
| Animals, Newborn | 5 | 2012 | 510 | 0.350 |
Why?
|
| Extremities | 2 | 2000 | 167 | 0.340 |
Why?
|
| Hippocampus | 3 | 2016 | 442 | 0.310 |
Why?
|
| Animals | 22 | 2019 | 26589 | 0.310 |
Why?
|
| Mice | 14 | 2019 | 11356 | 0.300 |
Why?
|
| Brain Stem | 2 | 2008 | 165 | 0.290 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2016 | 78 | 0.280 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2006 | 14 | 0.280 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 73 | 0.230 |
Why?
|
| GABA Antagonists | 3 | 2010 | 25 | 0.230 |
Why?
|
| Fever | 1 | 2003 | 125 | 0.210 |
Why?
|
| Motor Neurons | 2 | 2000 | 162 | 0.200 |
Why?
|
| Bicuculline | 3 | 2010 | 18 | 0.200 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2022 | 122 | 0.200 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2021 | 119 | 0.190 |
Why?
|
| Muscles | 2 | 2000 | 194 | 0.190 |
Why?
|
| Flufenamic Acid | 3 | 2010 | 13 | 0.180 |
Why?
|
| Electrophysiology | 3 | 2021 | 401 | 0.180 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2010 | 14 | 0.170 |
Why?
|
| Calcium Channels | 2 | 2011 | 182 | 0.170 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 57 | 0.160 |
Why?
|
| Brain | 2 | 2021 | 2216 | 0.160 |
Why?
|
| Drug Interactions | 2 | 2010 | 248 | 0.150 |
Why?
|
| Brachyura | 1 | 1997 | 1 | 0.150 |
Why?
|
| Mechanoreceptors | 1 | 1997 | 35 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2019 | 255 | 0.140 |
Why?
|
| Gamma Rhythm | 1 | 2016 | 14 | 0.140 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 27 | 0.140 |
Why?
|
| Electric Stimulation | 4 | 2016 | 347 | 0.140 |
Why?
|
| Glycine Agents | 2 | 2008 | 5 | 0.140 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2016 | 42 | 0.140 |
Why?
|
| Evoked Potentials | 1 | 2016 | 190 | 0.130 |
Why?
|
| Steroid 16-alpha-Hydroxylase | 1 | 2014 | 1 | 0.130 |
Why?
|
| Fear | 1 | 2014 | 78 | 0.120 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 44 | 0.120 |
Why?
|
| Transcriptome | 1 | 2019 | 580 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2014 | 79 | 0.120 |
Why?
|
| Neurotransmitter Agents | 2 | 2016 | 106 | 0.120 |
Why?
|
| Riluzole | 2 | 2011 | 15 | 0.120 |
Why?
|
| Potassium | 2 | 2004 | 281 | 0.110 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2012 | 5 | 0.110 |
Why?
|
| Memory | 1 | 2014 | 225 | 0.110 |
Why?
|
| Animals, Outbred Strains | 1 | 2012 | 15 | 0.110 |
Why?
|
| Cell Membrane | 3 | 2004 | 666 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 135 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 303 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2014 | 429 | 0.100 |
Why?
|
| Electrodes | 1 | 2011 | 78 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2016 | 3613 | 0.100 |
Why?
|
| Male | 12 | 2019 | 40973 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1961 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2011 | 126 | 0.090 |
Why?
|
| Exploratory Behavior | 2 | 2000 | 44 | 0.090 |
Why?
|
| Electromyography | 2 | 2000 | 183 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 324 | 0.090 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 203 | 0.090 |
Why?
|
| Imidazoles | 1 | 2010 | 162 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2000 | 297 | 0.080 |
Why?
|
| Biomechanical Phenomena | 2 | 2000 | 457 | 0.080 |
Why?
|
| Humans | 10 | 2022 | 86653 | 0.080 |
Why?
|
| Oxotremorine | 1 | 2008 | 4 | 0.080 |
Why?
|
| Strychnine | 1 | 2008 | 7 | 0.080 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 23 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 896 | 0.080 |
Why?
|
| Sodium Channel Blockers | 2 | 2004 | 27 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 339 | 0.080 |
Why?
|
| Child | 3 | 2016 | 6928 | 0.070 |
Why?
|
| Ketanserin | 1 | 2006 | 10 | 0.070 |
Why?
|
| Respiratory System Abnormalities | 1 | 2005 | 6 | 0.070 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2005 | 16 | 0.070 |
Why?
|
| Serotonin Antagonists | 1 | 2006 | 35 | 0.070 |
Why?
|
| Synapses | 1 | 2008 | 265 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2005 | 167 | 0.070 |
Why?
|
| Adolescent | 3 | 2016 | 8982 | 0.070 |
Why?
|
| Calcium | 1 | 2010 | 1156 | 0.060 |
Why?
|
| Heart | 1 | 2008 | 539 | 0.060 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 50 | 0.060 |
Why?
|
| Infant | 1 | 2011 | 3047 | 0.060 |
Why?
|
| Piperidines | 1 | 2006 | 181 | 0.060 |
Why?
|
| Hypoxia, Brain | 1 | 2004 | 41 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2004 | 151 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 912 | 0.060 |
Why?
|
| Amplifiers, Electronic | 1 | 2022 | 6 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 1221 | 0.050 |
Why?
|
| Female | 6 | 2021 | 44537 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 396 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 435 | 0.050 |
Why?
|
| Elastic Modulus | 1 | 2021 | 36 | 0.050 |
Why?
|
| Finite Element Analysis | 1 | 2021 | 74 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 111 | 0.050 |
Why?
|
| Oxygen | 1 | 2006 | 726 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 268 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 188 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 196 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 104 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2819 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2021 | 308 | 0.040 |
Why?
|
| Interneurons | 1 | 2000 | 93 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 3992 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 98 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 729 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 2 | 2010 | 15 | 0.040 |
Why?
|
| Models, Neurological | 2 | 2016 | 405 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 151 | 0.040 |
Why?
|
| Hypoxia | 1 | 2003 | 641 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 165 | 0.040 |
Why?
|
| Dopamine | 1 | 2019 | 275 | 0.040 |
Why?
|
| Isometric Contraction | 1 | 1997 | 38 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 5210 | 0.040 |
Why?
|
| Microelectrodes | 1 | 2016 | 81 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1924 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2016 | 87 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 118 | 0.030 |
Why?
|
| Biophysics | 1 | 2016 | 152 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2379 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 207 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 224 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2014 | 19 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 55 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2014 | 148 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2014 | 11 | 0.030 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 481 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 3095 | 0.030 |
Why?
|
| Astrocytes | 1 | 2014 | 139 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 806 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 210 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 297 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 214 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2426 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 39 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 937 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2010 | 51 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2010 | 45 | 0.020 |
Why?
|
| Piperazines | 1 | 2010 | 272 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3243 | 0.020 |
Why?
|
| Rett Syndrome | 1 | 2005 | 19 | 0.020 |
Why?
|
| Cadmium | 1 | 2004 | 28 | 0.020 |
Why?
|
| Lanthanum | 1 | 2004 | 16 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2004 | 32 | 0.020 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 10 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 87 | 0.010 |
Why?
|
| Ion Channels | 1 | 2004 | 246 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 25649 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1540 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 2232 | 0.010 |
Why?
|